U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
184381184381A Phase I/II Study of ABI-007 (Abraxane®, Nab®-Paclitaxel)and Vinorelbine in Patients With Stage IV (Metastatic) Breast CancerTerminatedHas ResultsStage IV (Metastatic) Breast CancerDrug: ABI-007|Drug: vinorelbine|Drug: Trastuzumab|Biological: G-CSFhttps://ClinicalTrials.gov/show/NCT00140140
184382184382Sublingual Versus Vaginal Misoprostol for Labor Induction at TermCompletedNo Results AvailableInduction of LaborDrug: Misoprostol (Cytotec®)https://ClinicalTrials.gov/show/NCT00140114
184383184383Safety and Efficacy of the ZoMaxxâ„¢ Drug-Eluting Stent System in Coronary ArteriesCompletedNo Results AvailableCoronary Disease|Coronary Artery Disease|Coronary RestenosisDevice: ZoMaxxâ„¢ Drug-Eluting Coronary Stent System|Device: TAXUSâ„¢ EXPRESS2â„¢ Paclitaxel Eluting Coronary Stenthttps://ClinicalTrials.gov/show/NCT00140101
184384184384Efficacy and Safety of ALGRX 3268 in Management of Needlestick Pain in Children.CompletedNo Results AvailableProcedural PainDrug: ALGRX 3268https://ClinicalTrials.gov/show/NCT00140088
184385184385Adjuvant Epirubicin/Cytoxan Followed By A Taxane VS. Epirubicin/Taxane As Treatment For Node-Positive Breast CancerCompletedNo Results AvailableAdenocarcinomaDrug: Epirubicin with Cyclophosphamide, followed by a Taxane|Drug: Epirubicin with a Taxanehttps://ClinicalTrials.gov/show/NCT00140075
184386184386Efficacy And Safety Of Xalatan Compared To Usual Care In Patients With Open Angle Glaucoma Or Ocular Hypertension.CompletedNo Results AvailableOcular Hypertension|Glaucoma, Open-AngleDrug: latanoprost 0.005% (Xalatan)https://ClinicalTrials.gov/show/NCT00140062
184387184387A 12week, Randomized, Evaluator-Masked, Parallel Group Comparing Evening Dosing Of Xalacom Vs Cosopt In Subj W/ GlaucomaCompletedNo Results AvailableGlaucoma, Open Angle|Ocular HypertensionDrug: Xalacom|Drug: Cosopthttps://ClinicalTrials.gov/show/NCT00140049
184388184388Pharmacogenomics Blood Sampling Protocol For Irinotecan/Fluorouracil/Leucovorin(CPT-11/FU/LV).CompletedNo Results AvailableColorectal NeoplasmsProcedure: Blood drawhttps://ClinicalTrials.gov/show/NCT00140036
184389184389Azithromycin Microspheres in Patients With Low Risk Community Acquired PneumoniaCompletedNo Results AvailableCommunity-Acquired PneumoniaDrug: Azithromycin microspheres 2.0 single dosehttps://ClinicalTrials.gov/show/NCT00140023
184390184390Erythropoietin Therapy for Subarachnoid HemorrhageCompletedNo Results AvailableAneurysmal Subarachnoid HemorrhageDrug: erythropoietin betahttps://ClinicalTrials.gov/show/NCT00140010
184391184391Environmental Treatment for Seasonal Affective Disorder (SAD)CompletedHas ResultsSeasonal Affective DisorderDevice: Litebook treatment devices|Device: Inactivated negative ion generatorhttps://ClinicalTrials.gov/show/NCT00139997
184392184392Ambulatory Blood Pressure Monitoring for Antihypertensive Treatment GuidanceCompletedNo Results AvailableHypertensionDevice: 24 hour blood pressure measurementhttps://ClinicalTrials.gov/show/NCT00139984
184393184393Phase III Study of Gemcitabine Compared With UFT in Patients With Completely Resected Pathological Stage IB-IIIa Non Small Cell Lung CancerRecruitingNo Results AvailableLung CancerDrug: gemicitabine 1000mg/m2, day1 and day 8, every 3 week, 6|Drug: UFT 250mg/m2, daily for 1 yearhttps://ClinicalTrials.gov/show/NCT00139971
184394184394Prognosis of Acute Coronary Syndrome in HIV-infected PatientsCompletedNo Results AvailableCoronary Heart Disease|HIV Infectionhttps://ClinicalTrials.gov/show/NCT00139958
184395184395Ghrelin, Growth Hormone and Cortisol Interaction in Growth Hormone Deficient PatientsCompletedNo Results AvailableHypopituitarismDrug: Human acylated ghrelinhttps://ClinicalTrials.gov/show/NCT00139945
184396184396Tiotropium Bromide Alone vs Tiotropium Bromide and Formoterol Fumarate in Subjects With COPD (Study P04272) (COMPLETED)CompletedNo Results AvailablePulmonary Disease, Chronic ObstructiveDrug: formoterol fumaratehttps://ClinicalTrials.gov/show/NCT00139932
184397184397Progressively Decreasing Titration Schedules of Bifeprunox in Subjects With Schizophrenia or Bipolar DisorderCompletedNo Results AvailableSchizophrenia|Schizoaffective Disorder|Bipolar DisorderDrug: Bifeprunoxhttps://ClinicalTrials.gov/show/NCT00139919
184398184398Twice Daily Titration Study of Bifeprunox in Subjects With SchizophreniaCompletedNo Results AvailableSchizophrenia|Schizoaffective DisorderDrug: Bifeprunoxhttps://ClinicalTrials.gov/show/NCT00139906
184399184399A Randomized, Open-label, Two-way Crossover Trial to Determine the Pharmacokinetics of Metoclopramide When Administered as the Orally Disintegrating Tablet Compared to Reglan® Tablets in Subjects With Diabetic GastroparesisCompletedNo Results AvailableDiabetic GastroparesisDrug: Reglan ODThttps://ClinicalTrials.gov/show/NCT00139893
184400184400A Single Center, Randomized, Double-blind, Crossover Pilot Trial Comparing the Onset of Action of Parcopa™ With Sinemet® in Subjects With Stable Parkinson's DiseaseCompletedNo Results AvailableParkinson's DiseaseDrug: Parcopahttps://ClinicalTrials.gov/show/NCT00139880
184401184401A Multicenter, Open-label Trial to Assess Subject Preference of PARCOPA, Carbidopa/Levodopa Orally Disintegrating Tablets, Compared to Conventional Carbidopa/Levodopa Tablets in Subjects With Stable Parkinson's DiseaseCompletedNo Results AvailableParkinson's DiseaseDrug: PARCOPAhttps://ClinicalTrials.gov/show/NCT00139867
184402184402A Multicenter, Open-Label, Randomized Crossover Trial to Assess Subject Preference for Alprazolam Orally Disintegrating Tablets Compared to Conventional Alprazolam Tablets in Subjects With AnxietyCompletedNo Results AvailableANXIETYDrug: Alprazolam orally disintegrating tabletshttps://ClinicalTrials.gov/show/NCT00139854
184403184403Safety and Efficacy of Treandaâ„¢ (Bendamustine HCl) in Patients With Indolent Non-Hodgkin's Lymphoma (NHL) Who Are Refractory to RituximabCompletedNo Results AvailableNon-Hodgkin's LymphomaDrug: Bendamustine HClhttps://ClinicalTrials.gov/show/NCT00139841
184404184404Post Marketing Study in Haemophilia B Patients Using Nonafact® (Human Coagulation Factor IX)CompletedNo Results AvailableHemophilia BDrug: human coagulation Factor IXhttps://ClinicalTrials.gov/show/NCT00139828
184405184405Michelangelo - Oasis 5CompletedNo Results AvailableMyocardial InfarctionDrug: Fondaparinux|Drug: enoxaparinhttps://ClinicalTrials.gov/show/NCT00139815
184406184406DANish Multicenter STENT TrialCompletedNo Results AvailableIschemic Heart Disease|Stable Angina|Unstable AnginaDevice: Coronary Stent Implantationhttps://ClinicalTrials.gov/show/NCT00139802
184407184407A Multicenter, Open-label Randomized Crossover Trial to Assess Subject Preference for Kemstroâ„¢ Compared to Conventional Baclofen Tablets in Subjects With Stable Multiple SclerosisCompletedNo Results AvailableMultiple SclerosisDrug: Kemstrohttps://ClinicalTrials.gov/show/NCT00139789
184408184408Study Of "Continuous Use" Of Celecoxib Vs. "Usual or Intermittent Use"CompletedHas ResultsOsteoarthritis, Knee|Osteoarthritis, HipDrug: Celecoxib|Drug: Celecoxibhttps://ClinicalTrials.gov/show/NCT00139776
184409184409US Inhaled Insulin Therapeutic Choice Questionnaire StudyCompletedNo Results AvailableDiabetes Mellitus, Type 2Procedure: Educational Materialshttps://ClinicalTrials.gov/show/NCT00139763
18441018441012 Week Evaluation of the Safety and Efficacy of 3 Doses of CP-526,555 and Placebo for Smoking CessationCompletedNo Results AvailableSmoking CessationDrug: CP-526,555 (varenicline)https://ClinicalTrials.gov/show/NCT00139750

* Görseller ve İçerik tekif hakkına sahip olabilir